Regulation of rabbit muscle phosphofructokinase by phosphorylation

The regulation of glycolytic enzymes in skeletal muscle is a key area of metabolic research. Phosphofructokinase (PFK) is central to glycolysis and its activity is influenced by its physical state within the cell. Prior studies have shown that PFK can exist in different oligomeric forms, such as dimers, tetramers, and octamers, which correlate with its enzymatic activity. However, the mechanism by which phosphorylation affects PFK's structural assembly remains unclear. Existing knowledge suggests that PFK's interaction with actin is modulated by phosphorylation, but the exact role of this modification in enzyme regulation is not fully understood. This uncertainty has driven investigations into how phosphorylation alters PFK's behavior in solution. Researchers have also noted that allosteric effectors like fructose-6-phosphate and citrate influence PFK activity, but the interplay between these effectors and phosphorylation is not well characterized. The lack of clarity regarding how phosphorylation and allosteric effectors jointly regulate PFK's assembly has created a gap in the field. This gap motivated the current study to explore the self-association of phosphorylated and dephosphorylated PFK forms under controlled conditions. By focusing on sedimentation velocity profiles, the study aimed to clarify the structural dynamics of PFK in response to phosphorylation and metabolite interactions.

This study aimed to investigate how phosphorylation influences the self-association of phosphofructokinase (PFK) in rabbit muscle. The researchers sought to determine whether phosphorylation alters the enzyme's tendency to form dimers, tetramers, or octamers. By analyzing sedimentation velocity profiles, the study aimed to clarify the structural changes in PFK when it is phosphorylated versus dephosphorylated. The researchers also wanted to assess how allosteric effectors like fructose-6-phosphate and citrate interact with phosphorylated and dephosphorylated PFK forms. The motivation for this work stems from the need to understand how phosphorylation modulates PFK's regulatory mechanism in muscle cells. The study's design focused on comparing the assembly behavior of PFK under different phosphorylation states and in the presence of specific metabolites. By examining the enzyme's response to these conditions, the researchers aimed to identify the role of phosphorylation in PFK's functional regulation. The ultimate goal was to determine how phosphorylation and allosteric effectors jointly influence PFK's structural dynamics and enzymatic activity.

The researchers used sedimentation velocity analysis to study the self-association of phosphorylated and dephosphorylated forms of phosphofructokinase (PFK). The experiments were conducted at pH 7.0 and 23 degrees Celsius to maintain physiological conditions. Different solvent constituents were used to observe how the enzyme's assembly behavior changed under varying environments. The study focused on the structural transitions between dimers, tetramers, and octamers of PFK. Allosteric effectors such as fructose-6-phosphate and citrate were introduced to assess their impact on the enzyme's assembly. The researchers monitored how these metabolites influenced the equilibrium constants for tetramerization and octamerization. The sedimentation velocity profiles were analyzed to determine the propensity of PFK to form different oligomeric states. Simulations were also performed to model the bimodal profiles observed in the experimental data and to compare them with previously reported findings.

The results showed that both phosphorylated and dephosphorylated forms of phosphofructokinase (PFK) exhibit the same mechanism of assembly. The presence of 0.2 mM fructose-6-phosphate significantly enhanced the formation of octamers without altering the equilibrium constant for tetramerization in either phosphorylated or dephosphorylated PFK. This suggests that fructose-6-phosphate promotes octamer formation regardless of the enzyme's phosphorylation state. In contrast, the presence of 10 mM citrate led to a significant increase in dimer formation, which is an inactive form of the enzyme. Citrate reduced the propensity of dephosphorylated PFK to tetramerize by 3000 times and phosphorylated PFK by 100 times. These findings indicate that citrate acts as an allosteric inhibitor by destabilizing the tetrameric form of PFK. The study also demonstrated that bimodal sedimentation velocity profiles could be simulated using different equilibrium constants. The simulations revealed that the diverse profiles reported in the literature could be explained by various combinations of these constants. Overall, the findings suggest that phosphorylation and allosteric effectors differentially influence PFK's structural assembly.

The study concluded that the phosphorylation state of phosphofructokinase (PFK) influences its structural assembly in a metabolite-dependent manner. The results suggest that phosphorylation does not change the fundamental mechanism of PFK's self-association but alters its response to specific metabolites. The presence of fructose-6-phosphate enhances octamer formation without affecting the equilibrium constant for tetramerization. This implies that fructose-6-phosphate may act as a stabilizing agent for the octameric form of PFK. In contrast, citrate significantly reduces the enzyme's tendency to tetramerize, leading to the formation of inactive dimers. These findings indicate that citrate functions as an allosteric inhibitor by disrupting the tetrameric structure of PFK. The study also showed that the bimodal sedimentation velocity profiles observed in PFK can be simulated using different equilibrium constants. This suggests that the diverse profiles reported in the literature may be explained by variations in these constants. The results support the idea that phosphorylation and allosteric effectors differentially regulate PFK's structural assembly. The authors propose that these findings provide new insights into the regulatory mechanisms of PFK in muscle cells.